Skip to main content
Caplight Logo









NuProbe

NuProbe

Private
Houston, TexasHealthcare & Life Scienceshttps://nuprobe.com/

Last Round

Series B

Jun 2, 2022

Total Funding Raised

$61M

Company Overview

NuProbe is a biotechnology company that develops ultrasensitive genomics and molecular diagnostic technologies for the early detection of cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Non-AI

Keywords

liquid biopsyblocker-displacement amplificationBDAnext-generation sequencingNGSminimal residual diseaseMRDcell-free DNAcfDNAmolecular diagnosticsgenomic assayprecision medicinecancer diagnosticsmutation detectiongenomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NuProbe Comparables

Compare NuProbe with similar companies based on industry and business-model similarity.

NuProbe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genecast
77%
Sysmex Corporation
74%
NeoGenomics Inc
73%

NuProbe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 2, 2022
VC RoundJan 11, 2021
Series AApr 23, 2018

NuProbe Investors

Notable investors and investment history

NuProbe investors
InvestorRounds
BioTrack CapitalSeries B, VC Round
A. M. Pappas & AssociatesSeries B
Shanghai Deguan Asset ManagementVC Round
CEC Capital GroupVC Round
Sequoia CapitalSeries B, Series A
Yonghua CapitalSeries B, VC Round
Serica PartnersVC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2018

    $11M round led by Sequoia Capital and Serica Partners

NuProbe Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NuProbe Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NuProbe's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range25
Year Founded2016
Last FundingJun 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?